United Kingdom

Profile: AnGes Inc (4563.T)

4563.T on Tokyo Stock Exchange

19 Apr 2019
Change (% chg)

¥46 (+5.64%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.

Company Address

AnGes Inc

7-7-15 Saito-asagi
Saito Bio-Incubator 4 Fl.
IBARAKI-SHI   OSK   567-0085
P: +813.57302641

Company Web Links